Telmisartan Tablet 40 mg (Telmisartan)

Adult dose

For essential hypertension, the recommended dose of Telmisartan is 40 mg orally once a day with water, regardless of meals. Depending on the patient, 20 mg once a day may be effective, and if necessary, the dose can be increased up to 80 mg once daily. For patients with liver impairment, do not exceed 40 mg once daily in cases of mild to moderate liver dysfunction. For reducing cardiovascular disease risk.

This drug may cause serious harm to the fetus and newborn, especially during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergic reactions to this medication or its ingredients, pregnant or breastfeeding women, patients with severe liver impairment or bile excretion disorder, patients with a history of hereditary angioedema, and those with specific kidney diseases or diabetes should not use this medication. Elderly patients or those with high serum potassium levels, patients with impaired liver function, or heart or kidney issues should use this medication with caution and closely monitor their condition before and after administration. During treatment with this drug, blood pressure, kidney function, electrolyte levels, etc. should be regularly monitored to detect and manage adverse reactions early. This drug has a blood pressure-lowering effect, which can cause symptoms of hypotension, dizziness, fainting, etc., so caution is needed when driving or operating hazardous machinery. This medication may interact with other antihypertensive drugs, certain diuretics, potassium supplements, and non-steroidal anti-inflammatory pain relievers, so it is essential to consult with a healthcare professional. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should avoid it or stop breastfeeding. In the case of an overdose, symptoms such as hypotension, dizziness, and kidney function deterioration may occur, so the patient should visit a medical institution immediately for appropriate treatment. This drug has not been proven safe and effective for children and is not recommended for use. The medication should be stored out of the reach of children, and before use, packaging should be checked carefully for hygienic use.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough + fever, yellowing of skin or eyes (jaundice), extreme fatigue, sudden and very severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urine

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is essential to maintain storage temperatures between 1°C and 30°C to ensure the effectiveness and safety of the medication for an extended period.

Appearance

White oval-shaped tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)], 30 tablets/bottle